April 23, 2020 / 10:36 AM / a month ago

Eli Lilly reports 15% rise in quarterly sales

April 23 (Reuters) - Eli Lilly and Co reported a 15.1% rise in first-quarter sales on Thursday, boosted by higher sales of its top-selling diabetes drug Trulicity and also benefiting from customers stockpiling its medicines amid the coronavirus pandemic.

Its quarterly revenue rose to $5.86 billion from $5.09 billion a year earlier.

However, net income fell to $1.46 billion, or $1.60 per share, in the quarter ended March 31, from $4.24 billion, or $4.31 per share, a year earlier when it recorded a gain of $3.68 billion from the sale of Elanco Animal Health..

Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Arun Koyyur

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below